Self-measured blood pressure (BP) at home (HBP) has a stronger predictive power for cardiovascular mortality and morbidity than casual-screening BP (CBP). No studies have evaluated the clinical significance of self-measured HBP for diagnosing metabolic syndrome (mS). Eight scientific associations recently defined mS for the Japanese population. However, this definition remains controversial, especially with respect to the cutoff value of waist circumference (WC) being higher in women than in men.
Metabolic syndrome (MS) is a cluster of metabolic risk factors that increases morbidity and mortality due to cardiovascular diseases (CVDs). 1, 2 The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III; 2001) defined and emphasized the importance of treatment for MS. 3 In Asia, as well as in other countries, MS is becoming a considerable threat due to rapid dietary and lifestyle changes. Therefore, the ATP III criteria have been commonly applied in Asia while an obesity-related anthropometric index in the criteria has been specifically designed for the U.S. population. Eight scientific associations recently collaborated to find a suitable definition of MS for the Japanese population. 4 However, such a definition remains controversial. The main issue is the higher cutoff value for female, than male waist circumference (WC). Some Japanese cohort studies have found that a lower female WC cutoff value in the Japanese MS criteria is needed to discriminate individuals with metabolic risk-factor clustering. [5] [6] [7] [8] [9] [10] In addition, health check-ups for MS among those aged ≥40 years of age will begin in April 2008 as a national policy with the objective of preventing lifestylerelated diseases. Conclusions gathered from additional evidence generated by population-based cohort studies should end the controversy.
Self-measured blood pressure (BP) at home (HBP) has a stronger predictive power for cardiovascular mortality and morbidity than casual-screening BP (CBP). [11] [12] [13] [14] Values of HBP improve the accuracy of screening for hypertension and for assessing BP control during treatment and encourage drug compliance. 15 Moreover, HBP measurements would provide articles Waist Cutoff and HBP to Define Metabolic Syndrome a cost benefit to diagnosing and treating hypertension. 15 However, no studies have yet attempted to improve the clinical significance of MS using HBP information.
This study proposes appropriate WC cutoff values as Japanese criteria for MS and evaluates the clinical significance of HBP for diagnosing MS.
METhOdS
Study population. This investigation is a part of a longitudinal observational study of HBP measurements among Ohasama residents that started in 1987. The socioeconomic and demographic characteristics of this region and full details of the project have been described elsewhere. 16 The study protocol was approved by the Institutional Review Board of Tohoku University School of Medicine, Sendai, Japan, and by the Department of Health of the Ohasama Town Government. Between 2000 and 2006, we attempted to contact all 4,809 individuals aged 35 years or over in four districts of Ohasama town. Those who were absent during the normal working hours of the study nurses (n = 1,298) and those hospitalized (n = 192) or incapacitated (n = 120) were not eligible. Of the remaining 3,199 residents, 2,181 (68%) provided written, informed consent to participate in the HBP measurement program. We excluded 68 individuals from the present analysis, as their morning HBP values were the averages of less than three readings (3 days). Of those, 397 volunteers (19%) participated in the diabetes screening program including the oral glucose tolerance test and measurement of WC. We excluded those treated with antidiabetic agents (n = 2) from the present analysis. The total number of participants statistically analyzed was thus 395. The 395 individuals who participated in the diabetes screening program were significantly older, had lower systolic HBP levels, and comprised a lower proportion of men than those who did not participate (n = 1786).
BP measurements. The participants measured HBP using a semi-automatic device (HEM-747IC-N; Omron Healthcare, Kyoto, Japan), which is based on the cuff-oscillometric method 17 that generates a digital display of both systolic and diastolic BP values. Physicians and public health nurses instructed the participants on how to use the device and record HBP. The participants measured their own BP once in the morning while seated within 1 h after waking, and after ≥2 min of rest and recorded the measurements for 4 weeks. Those on antihypertensive drugs measured BP before the morning dose. Although many participants measured BP at least twice per occasion, we used the first value from each measurement to exclude individual selection bias. 18 We defined HBP as the mean of all measurements.
During health check-ups held in Ohasama, nurses or technicians consecutively measured the CBP of seated participants twice using an automatic device (HEM-907, Omron Healthcare, Kyoto, Japan) after at least 2 min of rest. The CBP measurements were taken in the morning before the oral glucose tolerance test. The CBP was the average of two consecutive readings from each individual.
Both the HBP and CBP measuring devices used in this study have been validated 17, 19 and meet the criteria established by the Association for the Advancement of Medical Instrumentation. 20 Definition of metabolic risk-factor clustering. We first investigated the association between obesity-related anthropometric indices (WC or body mass index: BMI) and metabolic risk-factor clustering. Metabolic risk-factor clustering was defined based on the MS criteria for Japanese and of the ATP III, respectively. 3, 4 The Japanese-based criteria defined those with two or more of the following as having multiple risk factors: (i) triglycerides ≥150 mg/dl (1.7 mmol/l) and/or HDL cholesterol <40 mg/dl (1.03 mmol/l) and/or taking antihyperlipidemic drugs, (ii) fasting plasma glucose ≥ 110 mg/dl (6.1 mmol/l), and/or previously diagnosed with diabetes mellitus, (iii) CBP systolic ≥130 mm Hg and/or diastolic ≥85 mm Hg (in the CBP-based definition), or HBP systolic ≥125 mm Hg and/or diastolic ≥80 mm Hg (in the HBP-based definition) and/or taking antihypertensive drugs.
The ATP III-based criteria defined those with two or more of the following as having multiple risk factors: (i) triglycerides ≥150 mg/dl, (ii) HDL cholesterol <40 mg/dl in men, <50 mg/dl We also investigated whether HBP is more useful in diagnosing MS than CBP. Metabolic risk-factor clustering was also defined based on the MS criteria for Japanese or the ATP III, respectively. 3, 4 The Japanese-based criteria defined those with high WC (defined according to the first analysis) and any one of the following values as having multiple risk factors: (i) triglycerides ≥150 mg/dl and/or HDL cholesterol <40 mg/dl, and/ or taking antihyperlipidemic drugs, (ii) fasting plasma glucose ≥110 mg/dl and/or previously diagnosed with diabetes mellitus. The ATP III-based criteria defined two or more of the following as having multiple risk factors: (i) high WC (defined according to the first analysis), (ii) triglycerides ≥150 mg/dl, (iii) HDL cholesterol <40 mg/dl in men, <50 mg/dl in women, (iv) fasting plasma glucose ≥110 mg/dl.
Statistical analysis. Data were analyzed using the Wilcoxon rank-sum test and the χ 2 -test. We extracted samples in the first analysis using the Bootstrap method 24 and calculated the areas under receiver-operating characteristic curves (AUCs) by logistic regression analysis. The odds ratios for risk-factor clusters per 1 s.d. increase in CBP or HBP were examined using the logistic regression model adjusted for age and gender. All data are shown as means (s.d.) unless otherwise stated. Statistical significance was established at P < 0.05 (two-tailed). All statistical calculations were performed using the SAS system (version 9.1, SAS Institute).
RESulTS
The mean number of HBP measurements was 25 (5) . Table 1 shows the characteristics of the participants classified by gender. The WC in men was significantly higher than that in women. Table 2 shows the prevalence of each metabolic risk factor. According to the Japanese criteria, ~5% of the women had a WC of >90 cm, and the prevalence of MS among women was only 1.4%. The frequency of men taking diuretics among those prescribed with antihypertensive drugs tended to be higher than that of women. Table 3 shows the AUCs for identification of risk-factor clustering when defined based on WC or BMI. Among men, BMI tended to be associated with higher AUCs for the identification of any two or more risk factors other than WC regardless of BP information, whereas WC tended to have higher AUCs than BMI among women regardless of BP information. However, AUCs did not significantly differ between WC and BMI. When based on Japanese criteria, the AUCs for identifying three risk factors were distributed with wide 95% confidence intervals, since only a few individuals (n = 4 in both genders) had all three risk factors (data not shown). Table 4 shows the optimal cutoff values of WC and BMI for identifying HBP-based risk-factor clustering. The boundary values between the Japanese and ATP III criteria did not significantly differ. The appropriate cutoffs were WC ≥ 87 cm for men, ≥80 cm for women, and BMI ≥24 kg/m 2 for both genders.
The odds ratios for the presence of risk-factor clustering based on HBP were statistically significant (Figure 1) , whereas risk did not significantly increase when CBP was included in risk-factor clustering. We identified significant interactions between systolic CBP and systolic HBP (Japanese criteria, P = 0.04; ATP III criteria, P = 0.02). An analysis of these findings by gender indicated that the association was stronger in men than in women ( Table 5) .
We compared HBP readings over the first 3 days (3-day HBP) with the total 25 (5) day HBP (total HBP). The mean 3-day HBP values were 138 ± 18/82 ± 10 and 129 ± 18/76 ± 10 mm Hg for men and women, respectively. The results of the AUCs for identification of the risk-factor clustering by WC or BMI and the optimal cutoff values of WC and BMI for such identification were almost identical (data not shown). The odds ratios for the presence of risk-factor clustering per one standard deviation increase in the 3-day HBP were lower than in total HBP (data not shown).
diSCuSSiON
We found that the differences between WC and BMI as a component for a definition of MS were not statistically significant. If BMI was used as an obesity-related anthropometric index instead of WC, 24 kg/m 2 would be the optimal cutoff value. The present findings suggest a lower WC cutoff value (80 cm) for Japanese women than the current value based on the Japanese criteria for MS (90 cm). We also found that elevated HBP was associated with the clustering of metabolic risk factors.
The optimal cutoff values of WC based on the first analysis were 87 cm for men and 80 cm for women, and the latter value considerably differs from the current Japanese criterion of 90 cm. Ohkubo et al. 5 and Hara et al. 6 proposed cutoff articles Waist Cutoff and HBP to Define Metabolic Syndrome values of 75 cm and 78 cm, respectively, for Japanese women in relation to insulin resistance, and to metabolic risk-factor clustering except WC. Miyawaki et al. 7 and Eguchi et al. 8 also proposed cutoff values of 77 and 78 cm, respectively, in relation to visceral fat area. They both estimated visceral fat area cutoff points by gender to identify clustering of other risk factors or atherosclerotic CVD, and then calculated WC cutoff values corresponding to the visceral fat area cutoff points. Thus, lowering the standard value of WC for women compared to the current Japanese criteria for MS seems more reliable.
We could not identify a significant difference between the usefulness of WC and of BMI. Some studies have indicated that WC is more appropriate than BMI for a diagnosis of MS. 25, 26 Wildman et al. reported that WC in a Chinese population added further CVD risk information to that of BMI and vice versa. 27 However, reports addressing the predictive power of WC for CVD are sparse, whereas BMI has a proven predictive power for CVD and for coronary heart disease. 28 The prognostic value of WC remains to be investigated.
The optimal boundary value of BMI for diagnosing MS was 24 kg/m 2 for both genders. This result would be reasonable since the current standard of obesity in Japan is ≥25 kg/m 2 . 29 The cutoff WC value from the current study should also be reasonable since WC and BMI were calculated using the same analytical method.
Information about BP is necessary for a diagnosis of MS since the clinical state of MS includes having high BP. Whether CBP or HBP should be used to diagnose MS remains uncertain. The incidence of CVD is higher among individuals with MS than without MS. 30, 31 Since the BP information used in these reports was based on CBP, MS based on CBP would be a useful predictor of CVD. However, other investigators have reported that HBP has stronger predictive power for CVD morbidity and mortality than CBP. [11] [12] [13] [14] The present study revealed that HBP was more closely associated with clustering of metabolic risk factors than CBP. This association was closer in men than in women. The prevalence of masked hypertension (normal CBP and high HBP) was significantly higher among men than in women (25 and 12% in men and women, respectively; P < 0.01). We previously reported that masked hypertension has a powerful prognostic value for CVDs. 32 Measuring HBP would be effective for detecting masked hypertension among men. On the contrary, the prevalence of white-coat hypertension (high CBP and normal HBP) was significantly higher in women than in men (11 and 19% in men and women, respectively; P = 0.04). Ugajin et al. reported that white-coat hypertension is a transitional cause of sustained hypertension among Ohasama residents and suggested that white-coat hypertension would carry a poor cardiovascular prognosis. 33 Therefore, HBP measurement would be also important in women, as well as in men, for detecting the development of sustained hypertension. However, these unstable results with an extension of 95% confidence intervals indicate that further analyses are needed to define gender specificities. In general, a diagnosis of MS based on HBP would be a more powerful predictor of CVD than that of MS based on CBP. Although mass screening would be easier by measuring CBP than HBP, an accurate evaluation of metabolic risks using HBP would be necessary for therapeutic intervention. Approximately 30 million devices for measuring HBP are used in Japan, 34 and two thirds of treated hypertensive individuals in Italy and Greece are practicing HBP measurement. 35, 36 Therefore, mass screening by HBP measurement might be reasonably straightforward at present. Although the association between MS determined based on HBP and the prognosis of CVDs requires further study, we nevertheless suggest using HBP instead of CBP for diagnosing MS.
This study found that the Japanese and ATP III criteria were similarly associated with HBP values when we used cutoff values of WC calculated in first analysis that were applicable to the detection of MS risk-factor clustering. The ATP III criteria would be globally useful in comparisons of the prevalence of MS with that in other countries since they have been widely applied in investigations of prevalence and risk factors for MS. Further studies are required to clarify the appropriate cutoff values of WC and the applicability of the ATP III criteria to the Japanese population.
Among antihypertensive drugs, diuretics are associated with an increase in blood glucose and incidence of diabetes mellitus. 37 In this study, the prevalence of diuretic use was higher among men than women. This might influence the prevalence of fasting plasma glucose ≥110 mg/dl and MS (Japanese criteria). On the contrary, women were more frequently prescribed with antihyperlipidemic drugs than men in the present study. Generally, the serum lipid levels of Japanese women increase after menopause and exceed those of men. Thus, women >60 years of age are more often on antihyperlipidemic drugs than men. 38 Our results corresponded with this fact, since many women in this study were postmenopausal (63.4 ± 9.1 years old).
The odds ratios for the presence of risk-factor clustering per single standard deviation increase in 3-day HBP were lower than those in total HBP. We previously reported that the predictive value of HBP progressively increases with the number of measurements. 39 Therefore, the utility of HBP as MS criteria would likewise increase.
This study has some limitations. First, the participants are residents of a rural community and whether these results can be extrapolated to urban populations is debatable. The study cohort was significantly older, had lower systolic HBP levels, and comprised a lower proportion of men than nonparticipants. Those with sufficient time and health concerns might have been more likely to voluntarily participate. Moreover, diabetes is screened on weekdays, which might lead to a lower proportion of men. We included age and gender in the logistic regression models as major confounding factors. However, the possibility of selection bias needs to be considered when generalizing the present findings. Second, the number of participants was relatively small, so the frequency of having all risk factors was very low. Finally, this study was cross-sectional, so the cause-and-effect relationship was undetermined. A further articles Waist Cutoff and HBP to Define Metabolic Syndrome prospective study is required to assess whether HBP predicts the progression of MS and CVDs.
We concluded that the cutoff for WC among Japanese women should be lower than the current value of 90 cm. When BMI is used as an obesity-related anthropometric index instead of WC, the appropriate BMI cutoff for diagnosing MS would be 24 kg/m 2 . Furthermore, HBP (systolic ≥125 mm Hg and/or diastolic ≥80 mm Hg) would be more valuable than CBP for diagnosing MS.
